Search

Displaying results 11 - 20 of 62 in total
  1. Indication

    Dental Pain

    go.drugbank.com/conditions/DBCOND0031490
    Drugs: Benzocaine · Meloxicam
  2. Indication

    Foot and Ankle Surgeries

    go.drugbank.com/conditions/DBCOND0113622
    Drugs: Bupivacaine · Meloxicam
  3. Indication

    Acute Treatment of Migraine

    go.drugbank.com/conditions/DBCOND0082459
    Drugs: Meloxicam · Rizatriptan
  4. Indication

    Soft tissue surgery

    go.drugbank.com/conditions/DBCOND0128499
    Drugs: Bupivacaine · Meloxicam
  5. Indication

    NSAIDs

    go.drugbank.com/conditions/DBCOND0033500
    Drugs: Meloxicam · Nimesulide · Zucapsaicin
  6. Indication

    Polyarticular juvenile rheumatoid arthritis, chronic or unspecified

    go.drugbank.com/conditions/DBCOND0024827
    Drugs: Abatacept · Meloxicam · Sulfasalazine
  7. Drug

    Bupivacaine

    go.drugbank.com/drugs/DB00297
    ApprovedInvestigational

    Bupivacaine is a widely used local anesthetic agent.

    Categories: bupivacaine and meloxicam
  8. Drug

    Sodium hydroxide

    go.drugbank.com/drugs/DB11151
    Approved

    Sodium hydroxide is also known as lye or soda , or caustic soda . At room temperature, sodium hydroxide is a white crystalline odorless solid that absorbs moisture from the air. It is a synthetically manufactured substance. When dissolve...

    Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITI
  9. Drug

    Medium-chain triglycerides

    go.drugbank.com/drugs/DB13959
    ApprovedInvestigational

    Medium-chain triglycerides (MCTs) are triglycerides made up of a glycerol backbone and three fatty acids with an aliphatic tail of six to 12 carbon atoms. MCTs are found in natural foods, such as coconut oil, palm kernel oil, and raw coc...

    Mixtures: NUTRIPLUS LIPID SENZA ELETTROLITI, NUTRIPLUS LIPID SENZA ELETTROLITI
  10. Drug

    Rizatriptan

    go.drugbank.com/drugs/DB00953
    ApprovedInvestigational

    Rizatriptan is a second-generation triptan and a selective 5-HT1B and 5-HT1D receptor agonist. Used in the treatment of migraines, rizatriptan was first approved in the US in 1998. Rizatriptan is available in oral tablets, orally disinte...